Skip to main content
user-generated· Science

Will the NHS treat over 500 patients with Teplizumab for type 1 diabe…

Market overview

The NHS has made Teplizumab available, a drug to delay type 1 diabetes onset. This question assesses the initial uptake and accessibility of the drug within the first two years of its availability.

Science prediction market

Implied probability (Yes)
70%
Closes
2026-09-21

More Science markets

Browse all Science markets →

Loading…